1369489-71-3

E7046 is a potent and selective antagonist of the type 4 prostaglandin E2 (PGE2) receptor EP4.E7046 is an orally bioavailable and specific EP4 antagonist, with IC50 of 13.5 nM and Ki of 23.14 nM, exhibiting anti-tumor activities.